Rosuvastatin/Ezetimibe Versus Rosuvastatin in ASCVD Patients With Type 2 DM
Clinical trial NCT03597412 · COMPLETED
Trial details
- NCT number
- NCT03597412
- Sponsor
- Yuhan Corporation
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-17
- Primary completion
- 2020-08-12
- Enrollment
- 236
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.